Arvinas Inc

Research Arvinas Inc (ARVN) on Bullrun: market cap USD 534.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARVN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 534.88M
• Financial periodFY2025
• RevenueUSD 262.60M
• Revenue growth-0.3%
• Net income-USD 81.00M
• Free cash flow-USD 275.70M

Valuation Snapshot

latest market cap is USD 534.88M.

About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins.

Frequently asked questions

What is Arvinas Inc's market cap?

Arvinas Inc's market capitalization is USD 534.88M.

What does Arvinas Inc do?

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.